Literature DB >> 22963658

Feasibility and outcomes of laparoscopic renal intervention after prior open ipsilateral retroperitoneal surgery.

Ronald S Boris1, Gopal N Gupta, Jonas S Benson, W Marston Linehan, Peter A Pinto, Gennady Bratslavsky.   

Abstract

BACKGROUND AND
PURPOSE: Treating patients with renal-cell carcinoma (RCC) after previous retroperitoneal surgery (renal or adrenal) is technically challenging. We present our initial experience with laparoscopic renal interventions (LRI) after previous open retroperitoneal surgery in patients needing ipsilateral renal intervention. We report on feasibility, functional and oncologic outcomes of LRI after previous open retroperitoneal surgery. PATIENTS AND METHODS: We reviewed records of patients undergoing attempted laparoscopic or robot-assisted renal intervention after at least one previous open ipsilateral retroperitoneal surgery. We identified 34 patients who underwent 39 staged attempted LRI after 48 previous open ipsilateral renal or adrenal surgeries. The LRI included 20 minimally invasive partial nephrectomies (MIPN), 11 laparoscopic radiofrequency ablations (LRFA), and 8 laparoscopic nephrectomies (LTN). Demographic, perioperative, renal functional, and oncologic outcome data were collected. Statistical analyses were performed to identify risks for conversion to open surgery.
RESULTS: No attempted nephron-sparing procedure resulted in kidney loss. Overall conversion rate of the cohort was 28% and was highest in the MIPN group (40%). On univariate analysis, only multiple tumors that were treated significantly increased chances of open conversion (P<0.01). Subset analysis demonstrated similar rates of blood loss, operative times, and conversion rates in patients undergoing partial nephrectomy having previous open partial nephrectomy compared with previous open adrenal surgery only. There was no significant difference in preservation of renal function between MIPN and LRFA, with more than 85% of preoperative renal function preserved. Mean follow-up of 11.9 months (range 1-97.5 mos) metastasis-free survival and overall survival was 94.1% and 97%, respectively.
CONCLUSIONS: LRI after previous open ipsilateral retroperitoneal surgery is feasible. Repeated partial nephrectomy has the highest conversion risks among the laparoscopic renal interventions and appears to be independent of previous renal or adrenal procedure. Attempting repeated LRI for multiple tumors is a significant risk factor for open conversion. Renal functional and oncologic outcomes are encouraging at early follow-up.

Entities:  

Mesh:

Year:  2013        PMID: 22963658      PMCID: PMC3573724          DOI: 10.1089/end.2012.0483

Source DB:  PubMed          Journal:  J Endourol        ISSN: 0892-7790            Impact factor:   2.942


  30 in total

1.  Incidence of postoperative adhesion formation after transperitoneal genitourinary laparoscopic surgery.

Authors:  John G Pattaras; Robert G Moore; Jaime Landman; Ralph V Clayman; Gunter Janetschek; Elspeth M McDougall; Steven G Docimo; Raul O Parra; Louis R Kavoussi
Journal:  Urology       Date:  2002-01       Impact factor: 2.649

2.  Oncological outcomes of partial nephrectomy for multifocal renal cell carcinoma greater than 4 cm.

Authors:  Gopal N Gupta; James Peterson; Kailash N Thakore; Peter A Pinto; W Marston Linehan; Gennady Bratslavsky
Journal:  J Urol       Date:  2010-05-15       Impact factor: 7.450

3.  Guideline for management of the clinical T1 renal mass.

Authors:  Steven C Campbell; Andrew C Novick; Arie Belldegrun; Michael L Blute; George K Chow; Ithaar H Derweesh; Martha M Faraday; Jihad H Kaouk; Raymond J Leveillee; Surena F Matin; Paul Russo; Robert G Uzzo
Journal:  J Urol       Date:  2009-08-14       Impact factor: 7.450

4.  Repeat partial nephrectomy on the solitary kidney: surgical, functional and oncological outcomes.

Authors:  Nick W Liu; Kiranpreet Khurana; Sunil Sudarshan; Peter A Pinto; W Marston Linehan; Gennady Bratslavsky
Journal:  J Urol       Date:  2010-03-17       Impact factor: 7.450

5.  Prevalence of microscopic tumors in normal appearing renal parenchyma of patients with hereditary papillary renal cancer.

Authors:  D K Ornstein; I A Lubensky; D Venzon; B Zbar; W M Linehan; M M Walther
Journal:  J Urol       Date:  2000-02       Impact factor: 7.450

6.  The effect of previous abdominal surgery on urological laparoscopy.

Authors:  J Kellogg Parsons; Thomas J Jarrett; George K Chow; Louis R Kavoussi
Journal:  J Urol       Date:  2002-12       Impact factor: 7.450

7.  Feasibility of laparoscopic partial nephrectomy after previous ipsilateral renal procedures.

Authors:  Burak Turna; Monish Aron; Rodrigo Frota; Mihir M Desai; Jihad Kaouk; Inderbir S Gill
Journal:  Urology       Date:  2008-06-24       Impact factor: 2.649

8.  Partial nephrectomy after previous radio frequency ablation: the National Cancer Institute experience.

Authors:  Keith J Kowalczyk; H Brooks Hooper; W Marston Linehan; Peter A Pinto; Bradford J Wood; Gennady Bratslavsky
Journal:  J Urol       Date:  2009-09-16       Impact factor: 7.450

9.  Conversion during laparoscopic surgery: frequency, indications and risk factors.

Authors:  Lee Richstone; Casey Seideman; Lauren Baldinger; Sompol Permpongkosol; Thomas W Jarrett; Li-Ming Su; Christian Pavlovich; Louis R Kavoussi
Journal:  J Urol       Date:  2008-07-17       Impact factor: 7.450

10.  Initial experience with robot assisted partial nephrectomy for multiple renal masses.

Authors:  Ronald Boris; Miguel Proano; W Marston Linehan; Peter A Pinto; Gennady Bratslavsky
Journal:  J Urol       Date:  2009-08-14       Impact factor: 7.450

View more
  2 in total

1.  Organ-sparing procedures in GU cancer: part 1-organ-sparing procedures in renal and adrenal tumors: a systematic review.

Authors:  Raouf Seyam; Mahmoud I Khalil; Mohamed H Kamel; Waleed M Altaweel; Rodney Davis; Nabil K Bissada
Journal:  Int Urol Nephrol       Date:  2019-01-08       Impact factor: 2.370

2.  Ischemia Techniques in Nephron-sparing Surgery: A Systematic Review and Meta-Analysis of Surgical, Oncological, and Functional Outcomes.

Authors:  Francesco Greco; Riccardo Autorino; Vincenzo Altieri; Steven Campbell; Vincenzo Ficarra; Inderbir Gill; Alexander Kutikov; Alex Mottrie; Vincenzo Mirone; Hendrik van Poppel
Journal:  Eur Urol       Date:  2018-10-13       Impact factor: 24.267

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.